"DelRicht Research partners with investigators & sponsors to conduct clinical research trials at the highest level of quality & patient engagement."

During the past decade, DelRicht Research conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "DelRicht Research" #1 sponsor was "Alfasigma S.p.A." with 1 trials, followed by "Eli Lilly and Company" with 1 trials sponsored, "Evofem Inc." with 1 trials sponsored, "Incyte Corporation" with 1 trials sponsored and "Neurana Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "DelRicht Research" #1 collaborator was "bioRASI, LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "DelRicht Research" are "Migraine" (2 trials), "Acute Pain" (1 trials), "Back Muscle Spasm" (1 trials), "Back Pain" (1 trials) and "Back Spasm Upper" (1 trials). Many other conditions were trialed in "DelRicht Research" in a lesser frequency.

Most popular intervention types in "DelRicht Research" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Dihydroergotamine" (1 trials), "EVO100" (1 trials), "Galcanezumab" (1 trials) and "Rifaximin" (1 trials). Other intervention names were less common.

The vast majority of trials in "DelRicht Research" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "DelRicht Research". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in DelRicht Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in DelRicht Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".